Intraocular lens (IOL) implantation is the standard technique to treat cataract but posterior capsule opacification is one of the sill remaining postoperative complications. To address this problem we have developed a drug delivery polymer allowing repeated drug release in a non-invasive and controlled manner. The concept was successfully demonstrated in vitro.

© 2008 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription